We interpret the clinical and mechanistic data obtained for different agents that enable weight loss and glucose control for the treatment of obesity and type 2 diabetes mellitus, respectively, by activating or blocking GIPR signalling, including the GIPRGLP1R co-agonist tirzepatide, as well as the GIPR antagonistGLP1R agonist AMG-133
Some experimental work has explored L-carnitine in contexts involving heart rhythm changes during ischemic conditions, which underscores that this is a medically nuanced areanot a DIY project (Suzuki Y, 1981)
While on Wegovy for weight loss, youll likely need to eat smaller portions than before
They are protected by a portfolio of overlapping patents covering different aspects of the product, each with its own expiration date
For example, studies have been looking at the use of GLP-1s for reducing the risk of cardiovascular disease and chronic kidney disease, treatment of nonalcoholic fatty liver disease and Now, two new studies recently presented at the 2026 Annual Meeting of the American Academy of Orthopaedic Surgeons (AAOS) offer insights on how GLP-1 medications might influence musculoskeletal health, both positively and negatively